Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7 Å resolution

Structure

Volumn 8, Issue 6, 2000, Pages 605-615

  Schröder, Ewald ^a   Littlechild, Jennifer A ^a   Lebedev, Andrey A ^a   Errington, Neil ^b   Vagin, Alexei A ^c   Isupov, Michail N ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Decamer; Peroxidase; Peroxiredoxin; Sulphinic acid; Thioredoxin

Indexed keywords

PEROXIREDOXIN;

ARTICLE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; ENZYME PURIFICATION; ENZYME STABILITY; ENZYME STRUCTURE; ERYTHROCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0343953384     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(00)00147-7     Document Type: Article

References (50)

1. Butterfield L.H., Merino A., Golub S.H., Shau H. From cytoprotection to tumor suppression: the paradoxical role of peroxiredoxins. Antiox. Redox. Signal. 1:1999;385-402.
2. Jin D-Y., Jeang K-T. Peroxiredoxins in cell signalling and HIV infection. Sen C., Sies H., Baeuerle P. Antioxidants and Redox Regulation of Genes. 1999;381-407 Academic Press, NY, USA.
3. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 3rd Edition:1999;Oxford University Press, UK.
4. Schröder E., Willis A.C., Ponting C.P. Porcine natural killer enhancing factor-B: oligomerisation and identification as a calpain substrate in vitro. Biochim. Biophys. Acta. 1384:1998;279-291.
5. Chae H.Z., Chung S.J., Rhee S.G. Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269:1994;27 670-27 678.
6. Ellis H.R., Poole L.B. Roles for the two cysteine residues of AhpC in catalysis of peroxide reduction by alkyl hydroperoxide reductase from Salmonella typhimurium. Biochemistry. 36:1997;13 349-13 356.
7. Kang S.W., Baines I.C., Rhee S.G. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem. 273:1998;6303-6311.
8. Shau H., Butterfield L.H., Chiu R., Kim A. Cloning and sequence analysis of candidate human natural killer enhancing factor genes. Immunogenetics. 40:1994;129-134.
9. Cha M., Kim I. Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell. Biochem. Biophys. Res. Comm. 217:1995;900-907.
10. + transport in erythrocyte membrane vesicles requires a cytoplasmic protein. J. Biol. Chem. 266:1991;18 964-18 968.
11. Moore R.B., Shriver S.K. The cDNA sequence for calpromotin indicates that it plays a significant role in the proliferation and differentiation of hematopoietic-cells. Blood. 84:1994;A573.
12. Kristensen P., Rasmussen D.E., Kristensen B.I. Properties of thiol-specific anti-oxidant protein or calpromotin in solution. Biochem. Biophys. Res. Commun. 262:1999;127-131.
13. Harris J.R. Some negative contrast staining features of a protein from erythrocyte ghosts. J. Mol. Biol. 46:1969;329-335.
14. Harris J.R., Naeem I. Further studies on the characterisation of cylindrin and torin, two extrinsic proteins of the erythrocyte membrane. Biochim. Biophys. Acta. 670:1981;285-290.
15. Allen D.W., Cadman S. Calcium-induced erythrocyte membrane changes. The role of adsorption of cytosol proteins and proteases. Biochim. Biophys. Acta. 551:1979;1-9.
16. Rabilloud T., Berthier R., Vincon M., Ferbus D., Goubin G., Lawrence J.J. Early events in erythroid differentiation: accumulation of the acidic peroxiredoxin. Biochem. J. 312:1995;699-705.
17. Shau H., Paglia D.E.et al. Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stress. Free Rad. Biol. Med. 22:1997;497-507.
18. Kitano K., Niimura Y., Nishiyama Y., Miki K. Stimulation of peroxidase activity by decamerization related to ionic strength: AhpC protein from Amphibacillus xylanus. J. Biochem. 126:1999;313-319. (Tokyo).
19. Plishker G.A., Chevalier D., Seinsoth L., Moore R.B. Calcium-activated potassium transport and high molecular weight forms of calpromotin. J. Biol. Chem. 267:1992;21 839-21 843.
20. Schröder E., Ponting C.P. Evidence that peroxiredoxins are novel members of the thioredoxin fold superfamily. Protein Sci. 7:1998;2465-2468.
21. Choi H.J., Kang S.W., Yang C.H., Rhee S.G., Ryu S.E. Crystal structure of a novel human peroxidase enzyme at 2.0 Å resolution. Nat. Struct. Biol. 5:1998;400-406.
22. Hirotsu S., Hakoshima T.et al. Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23 kDa/proliferation-associated gene product. Proc. Natl Acad. Sci. USA. 96:1999;12 333-12 338.
23. Schröder E., Isupov M.N., Naran A., Littlechild J.A. Crystallisation and preliminary X-ray analysis of human thioredoxin peroxidase B from red blood cells. Acta Crystallogr. D. 55:1999;536-538.
24. Murshudov G.N., Dodson E.J. Simplified error estimation a la Cruickshank in macromolecular crystallography. Winn M. CCP4 Newsletter on Protein Crystallography. No 33. 1997;31-39 Daresbury Laboratory, Warrington, UK.
25. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:1993;283-291.
26. Ramakrishan C., Ramachandran G.N. Stereochemical criteria for polypeptide and protein chain conformation. Biophys. J. 5:1965;909-933.
27. Richardson J.S. The anatomy and taxonomy of protein structure. Adv. Protein Chem. 34:1981;167-339.
28. Choi H.J., Kang S.W., Yang C.H., Rhee S.G., Ryu S.E. Crystallisation and preliminary X-ray studies of hORF6, a novel human antioxidant enzyme. Acta Crystallogr. D. 54:1998;436-437.
29. Holmgren A. Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulphide. Structure. 3:1995;239-243.
30. Claiborne A., Parsonage D.et al. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry. 38:1999;15 407-15 416.
31. Schröder E. Structural Studies of Mu-calpain, a Novel Calpain Substrate and a Papain-Leupeptin Complex. PhD thesis. 1994;University of Oxford, UK.
32. Dacie, J. (1988). Sickle-cell disease IV: pathology, the sickling phenomenon and pathogenesis. In The Haemolytic Anaemias Vol 2: The Hereditary Haemolytic Anaemias Part 2. pp. 178-239, 3rd Edtn. Churchill Livingstone, UK.
33. Joiner C.H. Cation transport and volume regulation in sickle red blood cells. Am. J. Physiol. 264:1993;C251-C270.
34. Moore R.B., Shriver S.K., Jenkins L.D., Mankad V.N., Shah A.K., Plishker G.A. Calpromotin, a cytoplasmic protein, is associated with the formation of dense cells in sickle cell anemia. Am. J. Hematol. 56:1997;100-106.
35. Moore R.B., Shriver S.K. Protein 7.2b of human erythrocyte membranes binds to calpromotin. Biochem. Biophys. Res. Commun. 232:1997;294-297.
36. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
37. Vagin A., Teplyakov A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30:1997;1022-1025.
38. Navaza J. AMoRe: An automated package for molecular replacement. Acta Crystallogr. D. 50:1994;157-163.
39. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum likelihood method. Acta Crystallogr. D. 53:1997;240-255.
40. Cowtan K.D. DM: an automated procedure for phase improvement by density modification. Bailey S., Wilson K. CCP4 Newsletter on Protein Crystallography. No 31. 1994;34-38 Daresbury Laboratory, Warrington, UK.
41. Jones T.A., Zou J-Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
42. Vaguine A.A. SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. Acta Crystallogr. D. 55:1999;191-205.
43. Lamzin V.S., Wilson K.S. Automated refinement of protein models. Acta Crystallogr. D. 49:1993;129-147.
44. Becker K., Savvides S.N., Keese M., Schirmer R.H., Karplus P.A. Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers. Nat. Struct. Biol. 5:1998;267-271.
45. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. 50:1994;760-763.
46. Rao G.S.J., Murthy H.M.K., Rao N.A., Vijayan M. N-Carbamoyl-DL-aspartic acid. Acta Crystallogr. B. 38:1982;1672-1674.
47. Laue T.M., Shah B.D., Ridgeway T.M., Pelletier S.L. Computer-aided interpretation of analytical sedimentation data for proteins. Harding S.E., Rowe A.J., Horton J.C. Analytical Ultracentrifugation in Biochemistry and Polymer Science. 1992;90-125 The Royal Society of Chemistry, London, UK.
48. Johnson M.L., Correia J.J., Yphantis D.A., Halvorson H.R. Analysis of data from the analytical ultracentrifuge by non-linear least-squares techniques. Biophys. J. 36:1981;575-588.
49. Bernstein F.C., Tasumi M.et al. The protein data bank: a computer based archival file for macromolecular structures. J. Mol. Biol. 112:1977;535-542.
50. Esnouf R.M. An extensively modified version of MOLSCRIPT that greatly enhanced coloring capabilities. J. Mol. Graph. 15:1997;132-134.